Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Over the past decade, mortality from gallbladder cancer has declined sharply in England and Wales, Scotland, the United States, and Canada, but has risen by 33% in Sweden. In all these countries, gallbladder cancer mortality rates are inversely related to cholecystectomy rates in the previous year. It is suggested that changes in cholecystectomy rates produce changes in the prevalence of cholelithiasis, and consequently in gallbladder cancer incidence and mortality. It is estimated that 1 fewer death from gallbladder cancer occurs for about every 100 cholecystectomies done during the preceding year. The possibility of preventing death from gallbladder cancer in the patient with asymptomatic cholelithiasis must be balanced, however, against the risks of surgery.

Original publication

DOI

10.1016/s0140-6736(81)90366-4

Type

Journal article

Journal

Lancet

Publication Date

25/07/1981

Volume

2

Pages

187 - 189

Keywords

Cholecystectomy, Cholelithiasis, Gallbladder Neoplasms, Humans, Risk, Sweden, United Kingdom, United States